Fidelis Capital Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
1,868
+117
+7% +$13.5K 0.01% 509
2026
Q1
$209K Buy
1,751
+15
+0.9% +$1.97K 0.01% 479
2025
Q4
$236K Hold
1,736
– – 0.02% 439
2025
Q3
$256K Buy
1,736
+43
+3% +$5.96K 0.02% 411
2025
Q2
$243K Buy
+1,693
New +$205K 0.02% 386
2025
Q1
– Sell
-1,718
Closed -$211K – 462
2024
Q4
$211K Sell
1,718
-245
-12% -$31K 0.02% 412
2024
Q3
$259K Sell
1,963
-134
-6% -$17.9K 0.03% 341
2024
Q2
$266K Sell
2,097
-191
-8% -$26K 0.04% 305
2024
Q1
$296K Buy
2,288
+42
+2% +$5.08K 0.04% 291
2023
Q4
$257K Buy
+2,246
New +$224K 0.06% 274

Other funds holding XYL

Fidelis Capital Partners's XYL Position: Q2 2026 in Review

Fidelis Capital Partners increased its Xylem (XYL) stake by 6.7% in Q2 2026, buying an estimated $13.5K and bringing the position to 1,868 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #509.

Fidelis Capital Partners first reported a position in XYL in Q4 2023 and has held it in 10 quarters since. The position peaked at $296K in Q1 2024. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Fidelis Capital Partners held 1,868 shares of Xylem worth $221K as of Q2 2026.
  • Fidelis Capital Partners bought 117 Xylem shares in Q2 2026, an estimated $13.5K.
  • Xylem made up 0.01% of Fidelis Capital Partners's portfolio in Q2 2026, its #509 holding.
  • Fidelis Capital Partners first reported a position in Xylem in Q4 2023 and has held it in 10 quarters since.
  • Fidelis Capital Partners's Xylem position peaked at $296K in Q1 2024.
  • 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.